Vivos Therapeutics Inc. (VVOS)
4.17
-0.05 (-1.18%)
At close: Jan 28, 2025, 1:59 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 13.80M | 16.02M | 16.89M | 13.07M | 11.39M | 3.79M |
| Cost of Revenue | 5.53M | 6.00M | 4.28M | 2.65M | 2.74M | 1.08M |
| Gross Profit | 8.27M | 10.02M | 12.60M | 10.41M | 8.66M | 2.71M |
| Operating Income | -17.30M | -25.03M | -19.47M | -8.71M | -10.58M | -8.34M |
| Interest Income | n/a | 89.00K | 117.00K | 79.61K | 21.13K | n/a |
| Pretax Income | -13.58M | -23.84M | -20.29M | -12.06M | -10.75M | -8.44M |
| Net Income | -13.58M | -22.66M | -20.29M | -8.82M | -10.89M | -8.54M |
| Selling & General & Admin | 24.85M | 34.38M | 31.34M | 18.40M | 18.48M | 10.44M |
| Research & Development | 100.00K | 200.00K | n/a | n/a | n/a | n/a |
| Other Expenses | 621.00K | 669.00K | 733.00K | 717.87K | 751.23K | 610.67K |
| Operating Expenses | 25.57M | 35.05M | 32.08M | 19.12M | 19.23M | 11.05M |
| Interest Expense | n/a | n/a | 14.00K | 96.68K | 137.88K | 102.97K |
| Selling & Marketing Expenses | 2.47M | 5.34M | 5.55M | 2.31M | 2.31M | 1.16M |
| Cost & Expenses | 31.10M | 41.05M | 36.36M | 21.78M | 21.97M | 12.13M |
| Income Tax | n/a | -1.19M | 5.00K | -3.23M | 137.88K | 102.97K |
| Shares Outstanding (Basic) | 1.22M | 920.48K | 849.32K | 728.38K | 496.43K | 461.93K |
| Shares Outstanding (Diluted) | 1.22M | 920.48K | 849.32K | 728.38K | 496.43K | 461.93K |
| EPS (Basic) | -11.14 | -24.62 | -23.89 | -12.11 | -21.94 | -18.49 |
| EPS (Diluted) | -11.14 | -24.62 | -23.89 | -12.11 | -21.94 | -18.49 |
| EBITDA | -16.68M | -24.36M | -19.54M | -11.24M | -9.87M | -7.73M |
| Depreciation & Amortization | 621.00K | 669.00K | 733.00K | 717.87K | 751.23K | 610.67K |